LA Jolla Pharma (LJPC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -49,969 | -23,240 | -78,185 | -53,298 | -32,047 |
| Depreciation Amortization | 581 | 281 | 730 | 510 | 310 |
| Accounts payable and accrued liabilities | -732 | -2,479 | 3,600 | -508 | -250 |
| Other Working Capital | -1,538 | -4,068 | 4,125 | 1,644 | -469 |
| Other Operating Activity | 10,426 | 7,462 | 11,021 | 11,554 | 7,371 |
| Operating Cash Flow | $-41,232 | $-22,044 | $-58,709 | $-40,098 | $-25,085 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,021 | -750 | -2,218 | -1,419 | -910 |
| Investing Cash Flow | $-2,021 | $-750 | $-2,218 | $-1,419 | $-910 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 119,554 | 119,554 | 149 | 85 | 85 |
| Financing Cash Flow | $119,554 | $119,554 | $149 | $85 | $85 |
| Beginning Cash Position | 65,926 | 65,926 | 126,704 | 126,467 | 126,467 |
| End Cash Position | 142,227 | 162,686 | 65,926 | 85,035 | 100,557 |
| Net Cash Flow | $76,301 | $96,760 | $-60,778 | $-41,432 | $-25,910 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,232 | -22,044 | -58,709 | -40,098 | -25,085 |
| Capital Expenditure | -2,021 | -750 | -2,218 | -1,419 | -910 |
| Free Cash Flow | -43,253 | -22,794 | -60,927 | -41,517 | -25,995 |